Enhancers activation by CRISPR/Cas9-based acetyltransferase rescues loss of function in CREBBP point mutant

Authors

Sarah S. Luke, The University of Texas MD Anderson Cancer Center
Haopeng Yang, The University of Texas MD Anderson Cancer Center
Michael R. Green, The University of Texas MD Anderson Cancer Center

Files

Program Affiliation

University Outreach - Bryn Mawr College

Keywords

B-cell Malignancies, gRNA, CREBBP, dCas9-P300, Lymphoma

Recommended Citation

Luke, Sarah S.; Yang, Haopeng; and Green, Michael R., "Enhancers activation by CRISPR/Cas9-based acetyltransferase rescues loss of function in CREBBP point mutant" (2023). 2023 Summer Experience. 27.
https://openworks.mdanderson.org/sumexp23/27